Nutrition
5 Minutes

Ozempic, Wegovy, Mounjaro and alcohol: can they be taken together?

Ozempic, Wegovy, Mounjaro and alcohol: is it OK?
Written by
Goodweigh Team
Reviewed by
Last change
13 November 2026
https://www.goodweigh.nl/blog/ozempic-wegovy-mounjaro-alcohol

Medically reviewed by Dr. Jaramillo, a doctor at Goodweigh. Last updated on 7 October 2026

Short answer from Dr. Jaramillo

Alcohol is not prohibited whilst taking Ozempic, Wegovy or Mounjaro, but it is strongly discouraged: both alcohol and these medicines slow down gastric emptying and irritate the stomach lining. This exacerbates nausea, vomiting and the risk of severe dehydration, particularly at the start of treatment and when the dose is increased. In people with diabetes, alcohol can also cause low blood sugar, and it is an independent risk factor for pancreatitis. The advice is to avoid alcohol or limit it to a maximum of one glass per day.

Dr. Jaramillo, doctor at Goodweigh

Want to find out more? Start your intake here

Ozempic, Wegovy, Mounjaro and alcohol: many users wonder whether they can be taken together. Some find they’re less keen on a drink, whilst others feel nauseous more quickly. In this blog, you’ll find out what is known, what symptoms you might notice, and what research shows about cutting down on alcohol. You’ll also find out when it’s best to avoid alcohol.

We will be discussing semaglutide (found in Ozempic, Wegovy, Rybelsus and the Wegovy tablet), tirzepatide (found in Mounjaro) and liraglutide (found in Saxenda).

Can you drink alcohol whilst taking Ozempic, Wegovy, Mounjaro, Saxenda or Rybelsus?

Alcohol is not prohibited whilst taking Wegovy, Ozempic, Mounjaro, Saxenda and Rybelsus. However, it may still have consequences.

Our doctors recommend avoiding alcohol as much as possible, as it can make nausea and vomiting worse. It can also increase the risk of severe dehydration and, in people with diabetes, the risk of low blood sugar. The NHG Standard on Obesity advises against drinking alcohol, or at least not more than one glass a day. Alcohol is also high in calories, which does not help if you are trying to lose weight. Read also about what to eat whilst taking GLP-1 medication.

What do you notice if you drink whilst on GLP-1 treatment?

The most common side effect is increased stomach discomfort. These medicines slow down the emptying of your stomach, so you feel less hungry. Nausea, vomiting, diarrhoea and constipation occur in more than 1 in 10 users of semaglutide, liraglutide and tirzepatide. Adding alcohol to an already sensitive stomach can significantly worsen these symptoms. Both alcohol and GLP-1 medication irritate the stomach lining and slow down gastric emptying, thereby increasing the risk of severe nausea, vomiting and heartburn.

In studies of Wegovy, more than 4 in 10 users experienced nausea. With Mounjaro, this figure was around a quarter to a third, and was more common during dose escalation, according to the patient information leaflet. Would you like to know what you can do to manage these symptoms? Then read about nausea associated with GLP-1 medication and the side effects of GLP-1 medication. It is best to avoid alcohol during the first few weeks of treatment and when your dose is increased.

Does it make you get drunk more quickly? We don’t know. The patient information leaflet for Mounjaro states that slower gastric emptying may affect how quickly other tablets or drinks containing medicines are absorbed. As far as we could find, no studies have been carried out on humans to determine whether this also applies to alcohol. Reports from users about getting drunk quickly or suffering from severe hangovers are anecdotal and do not constitute a proven effect.

Can GLP-1 medication help you drink less?

It’s possible, but there are still few studies, and those that do exist mainly focus on people with a diagnosed alcohol use disorder (AUD), not on casual drinkers. In a study published in JAMA Psychiatry, 48 people were randomly assigned to receive either a low dose of semaglutide or a placebo. They drank less during a laboratory trial. At home, they did not drink on fewer days, but they did consume fewer drinks on the days they did drink.

A Danish study published in The Lancet followed 108 people with an alcohol problem and obesity who were seeking help. When taking semaglutide, they had fewer days of heavy drinking, although they experienced mild to moderate gastrointestinal symptoms more frequently. A Danish registry study of people with diabetes showed a possible temporary protective effect in the first few months. As participants in this study were not randomly assigned, the evidence is weaker.

A systematic review of all studies to date reaches the same conclusion: the results look promising, but further research is needed. For Mounjaro (tirzepatide) and Saxenda (liraglutide), we found no controlled studies relating to alcohol problems. None of these medicines (Wegovy, Ozempic, Mounjaro, Saxenda or Rybelsus) has been approved for the treatment of alcohol-related problems. Are you struggling with your alcohol consumption? If so, speak to your GP about treatments that have been proven to work.

What happens if you vomit after drinking alcohol?

You lose fluid, and this is something to bear in mind with these medicines. The information for Wegovy states that you must drink plenty of fluids to prevent dehydration. Combining alcohol with these medicines increases fluid loss in two ways. Alcohol has an immediate diuretic effect, whilst nausea, vomiting or diarrhoea caused by GLP-1 medication further reduce fluid volume. Severe dehydration can reduce blood flow to the kidneys, resulting in a sudden deterioration in kidney function or acute kidney injury (AKI).

You should therefore drink water if you have been vomiting. If you continue to vomit, or if you have severe and persistent pain in your stomach area, contact a doctor immediately. Have you noticed any side effects? You can report them to Lareb.

When is it best to avoid alcohol?

Avoid alcohol, or discuss it with your doctor first, in three situations. The first is a previous episode of pancreatitis. Both heavy alcohol consumption and GLP-1/GIP medicines (such as Wegovy, Ozempic, Mounjaro, Saxenda and Rybelsus) have been linked to acute pancreatitis. Combining alcohol with these treatments may increase the risk of pancreatitis.

The second scenario is type 2 diabetes managed with insulin or a specific type of blood-sugar-lowering tablet. In this case, your blood sugar may become too low, for example when taking semaglutide. This combination requires consultation with your treating doctor. Ozempic is authorised for type 2 diabetes. Our doctors do not combine GLP-1 medication with these medicines.

The third is poor liver function. Wegovy is not recommended in cases of severely impaired liver function. Are you pregnant or planning to become pregnant? If so, discuss with your doctor whether you can take these medicines and drink alcohol.

Does it vary depending on the medication: Ozempic, Wegovy, Rybelsus, Mounjaro and Saxenda?

This does not apply to alcohol: the advice is the same for all five, and the points to bear in mind are very similar. The main difference lies in the active ingredient and in who uses the medicine. Ozempic and Rybelsus are authorised for type 2 diabetes. Wegovy and Saxenda are intended for obesity, whilst Mounjaro is intended for both.

The table summarises the information contained in the patient information leaflets. Would you like to know more about the differences? See the comparison of Ozempic, Wegovy, Mounjaro and Saxenda.

Medicine (active ingredient) Take care when using insulin or certain diabetes tablets Previous pancreatitis
Ozempic (semaglutide) Yes (risk of low blood sugar) Caution is advised
Wegovy (semaglutide) Yes (risk of low blood sugar) Caution is advised
Rybelsus (semaglutide) Yes (risk of low blood sugar) Reported with GLP-1 agents
Mounjaro (tirzepatide) Yes (risk of low blood sugar) Caution is advised
Saxenda (liraglutide) Yes (risk of low blood sugar) Reported with GLP-1 agents

‍

Oral semaglutide (Rybelsus and the Wegovy tablet) has its own guidelines: you should take it on an empty stomach with a maximum of 120 ml of plain water. You should then wait at least 30 minutes before eating, drinking (including alcohol) or taking any other medicines, to ensure it is properly absorbed. An aperitif immediately after taking your tablet is therefore strongly discouraged.

We do not have any reliable sources regarding alcohol for newer medicines such as retatrutide or orforglipron, so this advice applies only to the medicines mentioned in this blog.

Can you drink alcohol whilst taking the Wegovy tablet?

The Wegovy tablet contains the same active ingredient as the Wegovy injection: semaglutide. The advice regarding alcohol is therefore the same as for the injection: avoid alcohol as much as possible, as it can make nausea, vomiting and dehydration worse. If you do drink, limit yourself to no more than one glass a day.

With a tablet, you also need to consider when to take it. With Rybelsus, which is also a tablet containing semaglutide, you should take the tablet on an empty stomach and then wait at least 30 minutes before eating or drinking. So do not drink alcohol immediately after taking the Wegovy tablet. For the exact guidelines, follow the patient information leaflet for your tablet and your doctor’s advice. You can read more in ‘Wegovy tablet: oral semaglutide’.

Alcohol and GLP-1 medication: make an informed choice

There is no strict ban on alcohol whilst taking these medicines. Medical advice is to avoid alcohol or drink as little as possible, with a maximum of one glass per day according to the NHG Obesity Standard. Take care of your stomach, drink plenty of water and take extra care if you have diabetes, a history of pancreatitis or liver problems. Goodweigh will discuss these guidelines during the intake and throughout the coaching programme, to ensure the treatment is safe and suited to your situation.

‍

Quellen

Hendershot, C. S., Bremmer, M. P., Paladino, M. B., et al. (2025). Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 82(4), 395-405. https://pubmed.ncbi.nlm.nih.gov/39937469/

Klausen, M. K., Justesen, S. K., Pedersen, J. N., et al. (2026). Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. The Lancet, 407(10540), 1687-1698. https://pubmed.ncbi.nlm.nih.gov/42070571/

Wium-Andersen, I. K., Wium-Andersen, M. K., Fink-Jensen, A., et al. (2022). Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events. A nationwide register-based cohort and self-controlled case series study. Basic & Clinical Pharmacology & Toxicology, 131(5), 372-379. https://pubmed.ncbi.nlm.nih.gov/35968738/

Patel, S., et al. (2025). GLP-1 receptor agonists and alcohol use disorder: a systematic review. Alcohol and Alcoholism. https://pubmed.ncbi.nlm.nih.gov/41273789/

Nederlands Huisartsen Genootschap. (2025). NHG-Standaard Obesitas (M95), versie 2.1. https://richtlijnen.nhg.org/standaarden/obesitas

Farmacotherapeutisch Kompas. Semaglutide. https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/s/semaglutide

Farmacotherapeutisch Kompas. Liraglutide. https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/l/liraglutide

European Medicines Agency. Wegovy: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/wegovy-epar-product-information_nl.pdf

European Medicines Agency. Ozempic: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/ozempic-epar-product-information_nl.pdf

European Medicines Agency. Mounjaro: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/mounjaro-epar-product-information_nl.pdf

European Medicines Agency. Saxenda: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/saxenda-epar-product-information_nl.pdf

European Medicines Agency. Rybelsus: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/rybelsus-epar-product-information_nl.pdf

Frequently Asked Questions‍

Can I have a glass of wine whilst taking Ozempic or Wegovy?

It is not forbidden, but our doctors recommend avoiding alcohol as much as possible, as it can make nausea and vomiting worse. The NHG Standard on Obesity advises against alcohol, or at least no more than one glass a day.

Do I get drunk more quickly on Mounjaro or Ozempic?

As far as we could ascertain, this has not been investigated. With Mounjaro, the slower gastric emptying may alter the absorption of other oral medicines. It is not known whether this also applies to alcohol. Users’ experiences do not constitute evidence.

Do Mounjaro or Ozempic help with alcohol addiction?

That has not been proven. Small studies have been carried out on semaglutide (in Ozempic and Wegovy) in people with an alcohol problem, showing a slight reduction in the number of heavy drinking days. We found no controlled study on Mounjaro, and none of these medicines is approved as a treatment for alcohol dependence.

What should I do if I vomit after drinking alcohol?

Drink water to prevent dehydration and eat something light if you can. If you keep vomiting, or if you have severe pain in your stomach area that won’t go away, contact a doctor straight away.

Can I drink alcohol whilst taking Saxenda or Rybelsus?

Yes, but here too, the advice is to drink as little as possible. When taking Rybelsus, you should wait at least 30 minutes after taking your tablet before eating or drinking, including alcohol.